Impact of coronary artery calcium score screening on cardiovascular risk stratification of patients with atrial fibrillation undergoing ablation
Autores da FMUP
Participantes de fora da FMUP
- Fernandes, S
- Cruz, I
- Faria, R
- Almeida, J
- Fonseca, P
- Ferreira, N
- Primo, JJ
Unidades de investigação
Abstract
Introduction: There is a well-established association between atrial fibrillation (AF) and coronary artery disease. Coronary artery calcium score (CACS) is a helpful tool to refine cardiovascular (CV) risk stratification and inform on the best strategies for primary CV prevention. This study aims to evaluate the impact of opportunistic screening with CACS on risk stratification and decision of preventive therapies, in patients with AF. Methods: Cross-sectional study including patients with AF or atrial flutter undergoing cardiac computed tomography for ablation procedure planning, from 2017 to 2019. Baseline clinical and demographical data were collected. CACS was assessed in patients without coronary artery disease using the Agatston method. Results: A total of 474 patients were included (93% with AF, mean age of 58 & PLUSMN; 10 years, 62% male). CACS >0 was present in 254 (54%) patients. According to CACS and the Society of Cardiovascular Computed Tomography recommendations, 25% of the patients would be candidates for statin therapy and 17% would be candidates for changes in the current statin intensity; in 11 patients (8%) acetylsalicylic acid would be recommended. Discussion/Conclusion: In our study, more than half of the patients undergoing cardiac computed tomography before AF catheter ablation had CACS above zero. Our findings suggest that an opportunistic evaluation of CACS at the time of ablation can be an important tool to improve CV risk stratification, with important clinical and therapeutic implications.
Dados da publicação
- ISSN/ISSNe:
- 0008-6312, 1421-9751
- Tipo:
- Article
- Páginas:
- 427-433
- DOI:
- 10.1159/000532018
- Link para outro recurso:
- www.scopus.com
Cardiology S. Karger AG
Citações Recebidas na Web of Science: 1
Citações Recebidas na Scopus: 3
Documentos
- Não há documentos
Filiações
Keywords
- PROGNOSTIC VALUE; DISEASE; PREVALENCE; ADULTS
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies (F-CHECK) - NCT05409846
Investigador Principal: Elisabete Lousada Martins Oliveira Bernardes
Estudo Observacional Académico (F-CHECK) . Sanofi . 2022
The Impact of Obesity on Cardiac Function and Morphology in Aortic Stenosis
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico (Obesity) . 2020
Suboptimal control of cardiovascular risk factors in myocardial infarction survivors
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico (myocard) . 2020
Modeling Aortic Stenosis progression: impact on follow-up, treatment, and survival
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico . 2022
Epicardial adipose tissue volume is not an independent predictor of atrial fibrillation recurrence after ablation
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico . 2022
Social Media Use by Cardiovascular Healthcare Professionals in Portugal
Investigador Principal: Ricardo José Araújo Ladeiras Lopes
Estudo Clínico Académico (Cardiovascular Healthca) . 2022
Flow-status in severe aortic stenosis for percutaneous valve implantation: Should we follow the flow?
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico . 2022
Cardiovascular Impact of Metabolic Syndrome: From Mechanisms to New Treatment Targets
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico . 2021
Citar a publicação
Fernandes S,Cruz I,Faria R,Almeida J,Fonseca P,Ferreira N,Primo JJ,Fontes R,Ladeiras R. Impact of coronary artery calcium score screening on cardiovascular risk stratification of patients with atrial fibrillation undergoing ablation. Cardiology. 2023. 148. (5):p. 427-433. IF:1,900. (4).